Aclarion, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
ACON
Aclarion, INCAclarion's 2024 10-K filing highlights its ongoing efforts to commercialize its NOCISCAN technology, secure payer contracts, and expand strategic relationships within the low back pain market.
NASDAQ
ACON
Aclarion, INC10-K: Aclarion, Inc. Files 10-K Report for Fiscal Year 2023, Outlines Financials and Strategic Outlook
Aclarion, Inc. released its 10-K filing for fiscal year 2023, detailing its financial performance, strategic initiatives, and future outlook in the healthcare technology sector.